Researchers discover new clue in the development of mania and bipolar disorder

October 25, 2011 at 10:08 am Leave a comment

Bipolar disorder and mania are debilitating psychiatric disorders characterized by extreme mood swings. In the manic phase, people are likely to experience phases of euphoria, grandiosity, and greater risk taking.

According to a recent government report, over half a million Canadians aged 15 or older reported that sometime in their life they had experienced symptoms of a manic episode.

Now, Greer S. Kirshenbaum, a doctoral student, and her colleagues in Dr. John Roder’s lab at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital are one step closer to uncovering the genetic basis of the disease. Their findings were published in the October 24 issue of Proceedings of the National Academy of Sciences.


The team studied genetically engineered mice that lack the sodium-potassium ATP-ase gene (known as ‘NKA’) and found that reduced NKA activity alters calcium levels. This triggers a cascade of signals in a communication pathway (termed ERK) previously known to be linked to bipolar disorder. As a result, the normal pattern of neuronal activity is disrupted, altering mood and behaviour.

“These findings are very exciting to see given that they offer the prospect of new therapies for bipolar disorder,” said Greer. “Our goal is to develop more effective treatments that target the root causes of the disorder.” Several recent studies have shown that current pharmacological treatments for bipolar disorder often fail to adequately address the most debilitating symptoms and can cause harsh side effects. Although the role of calcium channels and the ERK pathway have previously been investigated in psychiatric illnesses, the ATP-ase gene represents a new therapeutic target.

The study showed that the NKA inactivated mice displayed increased exploratory behaviour, faster walking, reduced sleeping times, greater risk-taking behaviour, and greater impulsivity—all of which are remarkably similar to the patterns of behaviour seen in humans during manic episodes of bipolar disorder.

In addition to these symptoms, Greer and her team found that the mania-like behaviour in the mice was reduced by treatment with lithium and valproic acid, which are two of the most commonly prescribed mood stabilizers. They also treated manic behaviour with two novel compounds that reduce ATP-ase activity.

“This new research follows up on a 50 year-old hypothesis that the sodium-potassium ATP-ase gene is involved in bipolar disorder, but this is the first genetic model that has been developed to study its role in mania and bipolar disorder,” said Greer. “What is most notable is that the mouse model can be readily applied to studying the gene’s effects in humans as well.”

The study received support from the Canadian Institutes of Health Research as well as the Ontario Mental Health Foundation.

Thanks to the Samuel Lunenfeld Research Institute for this story.

Entry filed under: Biotechnology News and Info from Canadian Universities.

An sneak peak at an innovation in proteomics Health File

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


biorad1

Bio-Rad Canada has sponsored the development of this site to advance the productivity of the Canadian Biotechnology sector and the fine people who work in it across the country.  We invite readers to contribute content: posters, tools, research and presentations, articles white papers, multimedia, music downloads and entertainment, conference announcements, videos. Please contact info@cbt20.ca for more information.

Bookmark and Share

Site developed by What If What Next(TM)

Follow us on Twitter


%d bloggers like this: